voriconazole has been researched along with Grippe in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chong, W; Saha, BK | 1 |
Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S | 1 |
Capellier, G; Clairet, AL; Lagoutte-Renosi, J; Millon, L; Navellou, JC; Piton, G; Rougny, AC; Winiszewski, H | 1 |
Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Woo, JH | 1 |
4 other study(ies) available for voriconazole and Grippe
Article | Year |
---|---|
A 61-Year-Old Man With Influenza Pneumonia and New Onset Hemoptysis.
Topics: Antifungal Agents; Diagnosis, Differential; Diagnostic Imaging; Fatal Outcome; Hemoptysis; Humans; Influenza, Human; Male; Middle Aged; Pneumonia, Viral; Pulmonary Aspergillosis; Voriconazole | 2021 |
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult | 2018 |
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopulmonary Sequestration; Extracorporeal Membrane Oxygenation; Humans; Influenza, Human; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles; Voriconazole | 2018 |
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antiviral Agents; Fatal Outcome; Humans; Immunocompetence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Oseltamivir; Pyrimidines; Triazoles; Voriconazole | 2012 |